BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol. 2008;38:259-267. [PMID: 18344316 DOI: 10.1093/jjco/hyn017] [Cited by in Crossref: 246] [Cited by in F6Publishing: 216] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Shida A, Mitsumori N, Nimura H, Takano Y, Iwasaki T, Fujisaki M, Takahashi N, Yanaga K. Prediction of lymph node metastasis and sentinel node navigation surgery for patients with early-stage gastric cancer. World J Gastroenterol 2016;22:7431-9. [PMID: 27672266 DOI: 10.3748/wjg.v22.i33.7431] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, Falck-Ytter Y, Mustafa RA. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology. 2020;158:693-702. [PMID: 31816298 DOI: 10.1053/j.gastro.2019.12.003] [Cited by in Crossref: 50] [Cited by in F6Publishing: 35] [Article Influence: 25.0] [Reference Citation Analysis]
3 Li P, Huang CM, Zheng CH, Russo A, Kasbekar P, Brennan MF, Coit DG, Strong VE. Comparison of gastric cancer survival after R0 resection in the US and China. J Surg Oncol. 2018;118:975-982. [PMID: 30332517 DOI: 10.1002/jso.25220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol. 2015;12:660-667. [PMID: 26260369 DOI: 10.1038/nrgastro.2015.128] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
5 Asaka M, Mabe K, Matsushima R, Tsuda M. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy. Gastroenterol Clin North Am. 2015;44:639-648. [PMID: 26314673 DOI: 10.1016/j.gtc.2015.05.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
6 Chan AW, Gill RS, Schiller D, Sawyer MB. Potential role of metabolomics in diagnosis and surveillance of gastric cancer. World J Gastroenterol. 2014;20:12874-12882. [PMID: 25278684 DOI: 10.3748/wjg.v20.i36.12874] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
7 Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A, Győrffy B. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 2016;7:49322-33. [PMID: 27384994 DOI: 10.18632/oncotarget.10337] [Cited by in Crossref: 488] [Cited by in F6Publishing: 496] [Article Influence: 162.7] [Reference Citation Analysis]
8 Ishibashi F, Fukushima K, Onizuka R, Tanaka R. Risk of progression to eosinophilic esophagitis in patients with asymptomatic esophageal eosinophilia: A retrospective pilot study. JGH Open 2020;4:422-8. [PMID: 32514448 DOI: 10.1002/jgh3.12270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kato M, Asaka M. Recent development of gastric cancer prevention. Jpn J Clin Oncol. 2012;42:987-994. [PMID: 23018579 DOI: 10.1093/jjco/hys151] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, Chotivitayatarakorn P, Treeprasertsuk S, Kositchaiwat C, Pisespongsa P, Mairiang P, Rani A, Leow A, Mya SM, Lee YC, Vannarath S, Rasachak B, Chakravuth O, Aung MM, Ang TL, Sollano JD, Trong Quach D, Sansak I, Wiwattanachang O, Harnsomburana P, Syam AF, Yamaoka Y, Fock KM, Goh KL, Sugano K, Graham D. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018;33:37-56. [PMID: 28762251 DOI: 10.1111/jgh.13911] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
11 Eybpoosh S, Talebkhan Y, Saberi S, Esmaeili M, Oghalaie A, Ebrahimzadeh F, Karimi T, Abdirad A, Nahvijou A, Mohagheghi MA, Eshagh Hosseini M, Mohammadi M. Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels. Iran Biomed J 2015;19:133-42. [PMID: 26117138 DOI: 10.7508/ibj.2015.03.002] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017;17:594-604. [PMID: 28860646 DOI: 10.1038/nrc.2017.68] [Cited by in Crossref: 91] [Cited by in F6Publishing: 64] [Article Influence: 22.8] [Reference Citation Analysis]
13 Lin JT. Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2014;12:135-138. [PMID: 24107396 DOI: 10.1016/j.cgh.2013.09.064] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
14 Shimoyama T, Aoki M, Sasaki Y, Matsuzaka M, Nakaji S, Fukuda S. ABC screening for gastric cancer is not applicable in a Japanese population with high prevalence of atrophic gastritis. Gastric Cancer. 2012;15:331-334. [PMID: 22282137 DOI: 10.1007/s10120-012-0141-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
15 Yao Y, Ding Y, Bai Y, Zhou Q, Lee H, Li X, Teng L. Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer. Front Genet 2020;11:591515. [PMID: 33597967 DOI: 10.3389/fgene.2020.591515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Werner S, Chen H, Tao S, Brenner H. Systematic review: serum autoantibodies in the early detection of gastric cancer. Int J Cancer. 2015;136:2243-2252. [PMID: 24615018 DOI: 10.1002/ijc.28807] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
17 Asaka M, Kato M, Graham DY. Strategy for eliminating gastric cancer in Japan. Helicobacter 2010;15:486-90. [PMID: 21073603 DOI: 10.1111/j.1523-5378.2010.00799.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
18 Ren JS, Kamangar F, Qiao YL, Taylor PR, Liang H, Dawsey SM, Liu B, Fan JH, Abnet CC. Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. Gut 2009;58:636-42. [PMID: 19136509 DOI: 10.1136/gut.2008.168641] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
19 Ito Y, Nakayama T, Tsukuma H, Miyashiro I, Ioka A, Sugimoto T, Rachet B. Role of age and tumour stage in the temporal pattern of 'cure' from stomach cancer: a population-based study in Osaka, Japan. Cancer Epidemiol 2012;36:128-32. [PMID: 22300953 DOI: 10.1016/j.canep.2011.12.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Charvat H, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Tsugane S; JPHC Study Group. Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer 2016;138:320-31. [PMID: 26219435 DOI: 10.1002/ijc.29705] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
21 Ngamruengphong S, Abe S, Oda I. Endoscopic Management of Early Gastric Adenocarcinoma and Preinvasive Gastric Lesions. Surg Clin North Am 2017;97:371-85. [PMID: 28325192 DOI: 10.1016/j.suc.2016.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wen KW, Rabinovitch PS, Huang D, Mattis AN, Lauwers GY, Choi W. Use of DNA flow cytometry in the diagnosis, risk stratification, and management of gastric epithelial dysplasia. Mod Pathol 2018;31:1578-87. [DOI: 10.1038/s41379-018-0062-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Yoshimizu S, Hirasawa T, Horiuchi Y, Omae M, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J. Differences in upper gastrointestinal neoplasm detection rates based on inspection time and esophagogastroduodenoscopy training. Endosc Int Open. 2018;6:E1190-E1197. [PMID: 30302376 DOI: 10.1055/a-0655-7382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014;47:478-489. [PMID: 25505712 DOI: 10.5946/ce.2014.47.6.478] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 9.7] [Reference Citation Analysis]
25 Lage J, Uedo N, Dinis-Ribeiro M, Yao K. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30:913-922. [PMID: 27938786 DOI: 10.1016/j.bpg.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
26 Tao J, Deng NT, Ramnarayanan K, Huang B, Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J. CD44-SLC1A2 gene fusions in gastric cancer. Sci Transl Med. 2011;3:77ra30. [PMID: 21471434 DOI: 10.1126/scitranslmed.3001423] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
27 Eishi H, Yamaguchi K, Hiramatsu Y, Akita K. Intra-mural distribution of the blood vessels in the stomach demonstrated by contrast medium injection: a cadaver study. Surg Radiol Anat 2021;43:389-96. [PMID: 33164135 DOI: 10.1007/s00276-020-02613-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yamaoka M, Nakajima S. Prevalence of subjects at a high or very high risk of gastric cancer in Japan. Gut Liver 2009;3:95-100. [PMID: 20431730 DOI: 10.5009/gnl.2009.3.2.95] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
29 Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol 2015;12:115-24. [PMID: 25384943 DOI: 10.1038/nrclinonc.2014.191] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 12.0] [Reference Citation Analysis]
30 Zhang H, Song Y, Xia P, Cheng Y, Guo Q, Diao D, Wang W, Wu X, Liu D, Dang C. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer. Med Oncol. 2014;31:830. [PMID: 24381142 DOI: 10.1007/s12032-013-0830-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
31 Lee HS, Jeon SW, Nomura S, Seto Y, Kwon YH, Nam SY, Ishibashi Y, Ohtsu H, Ohmoto Y, Yang HM. Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. Gastroenterol Res Pract. 2018;2018:1024074. [PMID: 29977284 DOI: 10.1155/2018/1024074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
32 Yamamoto K, Azuma M, Kuroda C, Kubo T, Yabunaka K, Yamazaki H, Katsuda T, Takeda Y. Radiation dose in mass screening for gastric cancer with high-concentration barium sulfate compared with moderate-concentration barium sulfate. Australas Phys Eng Sci Med 2009;32:88-91. [PMID: 19623859 DOI: 10.1007/BF03178633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Sato T. Image-enhanced endoscopy. Techniques in Gastrointestinal Endoscopy 2011;13:2-7. [DOI: 10.1016/j.tgie.2011.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Humphries JM, Penno MA, Weiland F, Klingler-Hoffmann M, Zuber A, Boussioutas A, Ernst M, Hoffmann P. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer. Biochim Biophys Acta. 2014;1844:1051-1058. [PMID: 24512919 DOI: 10.1016/j.bbapap.2014.01.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
35 Tepes B, Seruga M, Vujasinovic M, Urlep D, Ljepovic L, Brglez JN, Forte A, Anita Kek L, Skvarc M. Premalignant Gastric Lesions in Patients Included in National Colorectal Cancer Screening. Radiol Oncol 2018;52:7-13. [PMID: 29520200 DOI: 10.1515/raon-2017-0054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Min YW, Min BH, Lee JH, Kim JJ. Endoscopic treatment for early gastric cancer. World J Gastroenterol 2014;20:4566-73. [PMID: 24782609 DOI: 10.3748/wjg.v20.i16.4566] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
37 Huang RJ, Ende AR, Singla A, Higa JT, Choi AY, Lee AB, Whang SG, Gravelle K, D'Andrea S, Bang SJ, Schmidt RA, Yeh MM, Hwang JH. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Gastrointest Endosc 2020;91:70-77.e1. [PMID: 31425693 DOI: 10.1016/j.gie.2019.07.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
38 Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. Postgrad Med J. 2016; May 24. [Epub ahead of print]. [PMID: 27222587 DOI: 10.1136/postgradmedj-2016-133997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 17.7] [Reference Citation Analysis]
40 Cheng XJ, Lin JC, Tu SP. Etiology and Prevention of Gastric Cancer. Gastrointest Tumors 2016;3:25-36. [PMID: 27722154 DOI: 10.1159/000443995] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 11.2] [Reference Citation Analysis]
41 Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, Jung KW, Lee CW, Choi IJ, Park EC, Lee D. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology. 2017;152:1319-1328.e7. [PMID: 28147224 DOI: 10.1053/j.gastro.2017.01.029] [Cited by in Crossref: 145] [Cited by in F6Publishing: 106] [Article Influence: 36.3] [Reference Citation Analysis]
42 Hamashima C, Ogoshi K, Narisawa R, Kishi T, Kato T, Fujita K, Sano M, Tsukioka S. Impact of endoscopic screening on mortality reduction from gastric cancer. World J Gastroenterol. 2015;21:2460-2466. [PMID: 25741155 DOI: 10.3748/wjg.v21.i8.2460] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
43 Shi J, Cheng C, Ma J, Liew CC, Geng X. Gene expression signature for detection of gastric cancer in peripheral blood. Oncol Lett. 2018;15:9802-9810. [PMID: 29928354 DOI: 10.3892/ol.2018.8577] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 El Abiad R, Gerke H. Gastric Cancer: Endoscopic Diagnosis and Staging. Surgical Oncology Clinics of North America 2012;21:1-19. [DOI: 10.1016/j.soc.2011.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
45 Park CH, Kim EH, Chung H, Lee H, Park JC, Shin SK, Lee YC, An JY, Kim HI, Cheong JH. The optimal endoscopic screening interval for detecting early gastric neoplasms. Gastrointest Endosc. 2014;80:253-259. [PMID: 24613579 DOI: 10.1016/j.gie.2014.01.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
46 Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56:1177-85. [PMID: 26256958 DOI: 10.3349/ymj.2015.56.5.1177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
47 Matsuda A, Saika K, Tanaka R, Ito Y, Fukui K, Kamo KI. Simulation Models in Gastric Cancer Screening: A Systematic Review. Asian Pac J Cancer Prev 2018;19:3321-34. [PMID: 30583337 DOI: 10.31557/APJCP.2018.19.12.3321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Huang ZB, Zhang HT, Yu B, Yu DH. Cell-free DNA as a liquid biopsy for early detection of gastric cancer. Oncol Lett 2021;21:3. [PMID: 33240409 DOI: 10.3892/ol.2020.12264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
50 Da B, Jani N, Gupta N, Jayaram P, Kankotia R, Yao Yu C, Dinis-Ribeiro M, Buxbaum J. High-risk symptoms do not predict gastric cancer precursors. Helicobacter 2019;24:e12548. [PMID: 30412322 DOI: 10.1111/hel.12548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
51 Kobayashi D, Takahashi O, Arioka H, Fukui T. The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan. BMC Gastroenterol 2012;12:144. [PMID: 23072453 DOI: 10.1186/1471-230X-12-144] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
52 Coman RM, Gotoda T, Draganov PV. Training in endoscopic submucosal dissection. World J Gastrointest Endosc. 2013;5:369-378. [PMID: 23951392 DOI: 10.4253/wjge.v5.i8.369] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
53 Leja M, You W, Camargo MC, Saito H. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-1106. [PMID: 25439074 DOI: 10.1016/j.bpg.2014.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
54 Thompson CA, Gomez SL, Hastings KG, Kapphahn K, Yu P, Shariff-Marco S, Bhatt AS, Wakelee HA, Patel MI, Cullen MR, Palaniappan LP. The Burden of Cancer in Asian Americans: A Report of National Mortality Trends by Asian Ethnicity. Cancer Epidemiol Biomarkers Prev 2016;25:1371-82. [PMID: 27694108 DOI: 10.1158/1055-9965.EPI-16-0167] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
55 Nakagawa M, Choi YY, An JY, Chung H, Seo SH, Shin HB, Bang HJ, Li S, Kim HI, Cheong JH. Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study. BMC Cancer. 2015;15:943. [PMID: 26625983 DOI: 10.1186/s12885-015-1940-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
56 Penno MA, Klingler-Hoffmann M, Brazzatti JA, Boussioutas A, Putoczki T, Ernst M, Hoffmann P. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer. J Proteomics 2012;77:40-58. [PMID: 22789672 DOI: 10.1016/j.jprot.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
57 Compare D, Rocco A, Nardone G. Screening for and surveillance of gastric cancer. World J Gastroenterol. 2014;20:13681-13691. [PMID: 25320506 DOI: 10.3748/wjg.v20.i38.13681] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
58 Park CH, Kim EH, Chung H, Park JC, Shin SK, Lee YC, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH, Kim CB, Lee SK. Periodic Endoscopies Might Not Increase the Detection of Early Gastric Cancer in a Young Population. PLoS One 2016;11:e0159759. [PMID: 27448311 DOI: 10.1371/journal.pone.0159759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
59 Aikou S, Ohmoto Y, Gunji T, Matsuhashi N, Ohtsu H, Miura H, Kubota K, Yamagata Y, Seto Y, Nakajima A. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology. 2011;141:837-845.e1-7. [PMID: 21699780 DOI: 10.1053/j.gastro.2011.05.040] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
60 Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017;15:1833-1843. [PMID: 28532700 DOI: 10.1016/j.cgh.2017.05.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 23.3] [Reference Citation Analysis]
61 Asaka M, Kobayashi M, Kudo T, Akino K, Asaka Y, Fujimori K, Kikuchi S, Kawai S, Kato M. Gastric cancer deaths by age group in Japan: Outlook on preventive measures for elderly adults. Cancer Sci 2020;111:3845-53. [PMID: 32713120 DOI: 10.1111/cas.14586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
62 Li J, Li H, Zeng H, Zheng R, Cao M, Sun D, Ren J, Chen W, He J. A study protocol of population-based cancer screening cohort study on esophageal, stomach and liver cancer in rural China. Chin J Cancer Res 2020;32:540-6. [PMID: 32963466 DOI: 10.21147/j.issn.1000-9604.2020.04.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Suh Y, Yang H. Screening and Early Detection of Gastric Cancer. Surgical Clinics of North America 2015;95:1053-66. [DOI: 10.1016/j.suc.2015.05.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
64 Lee HY, Park EC, Jun JK, Choi KS, Hahm MI. Comparing upper gastrointestinal X-ray and endoscopy for gastric cancer diagnosis in Korea. World J Gastroenterol. 2010;16:245-250. [PMID: 20066745 DOI: 10.3748/wjg.v16.i2.245] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
65 Inoue K, Fujisawa T, Haruma K. Assessment of Degree of Health of the Stomach by Concomitant Measurement of Serum Pepsinogen and Serum Helicobacter Pylori Antibodies. Int J Biol Markers 2010;25:207-12. [DOI: 10.5301/jbm.2010.6087] [Cited by in Crossref: 24] [Article Influence: 8.0] [Reference Citation Analysis]
66 Choi KS, Jun JK, Lee H, Park S, Jung KW, Han MA, Choi IJ, Park E. Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea. Cancer Science 2011;102:1559-64. [DOI: 10.1111/j.1349-7006.2011.01982.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
67 Uedo N, Gotoda T, Yoshinaga S, Tanuma T, Morita Y, Doyama H, Aso A, Hirasawa T, Yano T, Uchita N, Ho S, Hsieh P. Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: A questionnaire survey: Routine EGD in Japan and overseas. Digestive Endoscopy 2016;28:16-24. [DOI: 10.1111/den.12629] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
68 Zhang CX, Wu CT, Xiao L, Tang SH. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis. Biomarkers. 2021;26:95-102. [PMID: 33401971 DOI: 10.1080/1354750x.2020.1871411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
69 Shuto M, Fujioka T, Matsunari O, Okamoto K, Mizukami K, Okimoto T, Kodama M, Takigami S, Seguchi C, Nonaka Y, Sato R, Yamaoka Y, Murakami K. Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers. Gastroenterol Res Pract 2017;2017:1286198. [PMID: 28690637 DOI: 10.1155/2017/1286198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: prevention, screening and early diagnosis. World J Gastroenterol. 2014;20:13842-13862. [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 146] [Cited by in F6Publishing: 126] [Article Influence: 24.3] [Reference Citation Analysis]
71 Mizuno S, Kobayashi M, Tomita S, Miki I, Masuda A, Onoyama M, Habu Y, Inokuchi H, Watanabe Y. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer. 2009;12:158-163. [PMID: 19890696 DOI: 10.1007/s10120-009-0522-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
72 Nakagawa M, Choi YY, An JY, Hong JH, Kim JW, Kim HI, Cheong JH, Hyung WJ, Choi SH, Noh SH. Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System. Ann Surg Oncol. 2016;23:4322-4331. [PMID: 27370654 DOI: 10.1245/s10434-016-5390-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
73 Guo TJ, Qin JY, Zhu LL, Wang J, Yang JL, Wang YP. Feasible endoscopic therapy for early gastric cancer. World J Gastroenterol 2015;21:13325-31. [PMID: 26715816 DOI: 10.3748/wjg.v21.i47.13325] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
74 Arrington AK, Nelson R, Patel SS, Luu C, Ko M, Garcia-Aguilar J, Kim J. Timing of chemotherapy and survival in patients with resectable gastric adenocarcinoma. World J Gastrointest Surg 2013;5:321-8. [PMID: 24392183 DOI: 10.4240/wjgs.v5.i12.321] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
75 De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer. Clin Transl Gastroenterol 2016;7:e183. [PMID: 27441820 DOI: 10.1038/ctg.2016.42] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
76 Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Japanese Journal of Clinical Oncology 2018;48:278-86. [DOI: 10.1093/jjco/hyx190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
77 Qian W, Bai T, Wang H, Zhang L, Song J, Hou XH. Meta-analysis of confocal laser endomicroscopy for the diagnosis of gastric neoplasia and adenocarcinoma: Meta-analysis: CLE detection of GIN & GC. Journal of Digestive Diseases 2016;17:366-76. [DOI: 10.1111/1751-2980.12357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
78 Uedo N, Yao K, Ishihara R. Screening and treating intermediate lesions to prevent gastric cancer. Gastroenterol Clin North Am. 2013;42:317-335. [PMID: 23639643 DOI: 10.1016/j.gtc.2013.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
79 Schmidt B, Yoon SS. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol. 2013;107:259-264. [PMID: 22513454 DOI: 10.1002/jso.23127] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
80 Park HA, Nam SY, Lee SK, Kim SG, Shim K, Park SM, Lee S, Han HS, Shin YM, Kim K, Lee K, Lee T, Choi IJ, Hong SS, Kim JW, Lee YJ, Kim SY, Kim Y, Lee W, Chung IK. The Korean guideline for gastric cancer screening. J Korean Med Assoc 2015;58:373. [DOI: 10.5124/jkma.2015.58.5.373] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
81 Zhang Y, Li Z, Fan X, Xiong J, Zhang G, Luo X, Li K, Jie Z, Cao Y, Huang Z, Wu F, Xiao L, Duan G, Chen H. PRL-3 promotes gastric cancer peritoneal metastasis via the PI3K/AKT signaling pathway in vitro and in vivo. Oncol Lett 2018;15:9069-74. [PMID: 29805638 DOI: 10.3892/ol.2018.8467] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
82 Huang Z, Zhang X, Lu H, Wu L, Wang D, Zhang Q, Ding H. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China. BMC Gastroenterol 2014;14:74. [PMID: 24720760 DOI: 10.1186/1471-230X-14-74] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
83 Lou N, Zhang L, Chen XD, Pang WY, Arvine C, Huang YP, Zhuang CL, Shen X. A novel scoring system associating with preoperative platelet/lymphocyte and clinicopathologic features to predict lymph node metastasis in early gastric cancer. J Surg Res 2017;209:153-61. [PMID: 28032552 DOI: 10.1016/j.jss.2016.10.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
84 Symeonidis D, Koukoulis G, Tepetes K. Sentinel node navigation surgery in gastric cancer: Current status. World J Gastrointest Surg 2014;6:88-93. [PMID: 24976901 DOI: 10.4240/wjgs.v6.i6.88] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
85 Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter. 2014;19:425-436. [PMID: 25164596 DOI: 10.1111/hel.12150] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
86 Choi KS, Jun JK, Park EC, Park S, Jung KW, Han MA, Choi IJ, Lee HY. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One. 2012;7:e50041. [PMID: 23209638 DOI: 10.1371/journal.pone.0050041] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
87 Rajkumar T, Vijayalakshmi N, Gopal G, Sabitha K, Shirley S, Raja UM, Ramakrishnan SA. Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int. 2010;10:45. [PMID: 21092330 DOI: 10.1186/1475-2867-10-45] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 5.1] [Reference Citation Analysis]
88 Filomena A, Saieva C, Lucchetti V, Santacroce F, Falorni P, Francini V, Carrieri P, Zini E, Ridolfi B, Belli P. Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results. Digestion. 2011;84:70-77. [PMID: 21494036 DOI: 10.1159/000322689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
89 Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K. Endoscopic screening for gastric cancer in Japan: Current status and future perspectives. Dig Endosc 2021. [PMID: 34143908 DOI: 10.1111/den.14063] [Reference Citation Analysis]
90 Nakashima H, Nagahama R, Yamamoto T, Ohkura Y. Mass screening for gastric cancer: how to select patients for endoscopic examination. Gastric Cancer. 2010;13:78-83. [PMID: 20602193 DOI: 10.1007/s10120-009-0538-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
91 Goto A, Nishikawa J, Kiyotoki S, Nakamura M, Nishimura J, Okamoto T, Ogihara H, Fujita Y, Hamamoto Y, Sakaida I. Use of hyperspectral imaging technology to develop a diagnostic support system for gastric cancer. J Biomed Opt 2015;20:016017. [PMID: 25604546 DOI: 10.1117/1.JBO.20.1.016017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
92 Asaka M. A new approach for elimination of gastric cancer deaths in Japan. Int J Cancer. 2013;132:1272-1276. [PMID: 23180638 DOI: 10.1002/ijc.27965] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 9.3] [Reference Citation Analysis]
93 Yatake H, Takeda Y, Katsuda T, Kuroda C, Yamazaki H, Gotanda R, Gotanda T, Yabunaka K, Nagamatsu M. Improved detection of gastric cancer during screening by additional radiographs as judged necessary by the radiographer. Jpn J Radiol 2011;29:177-86. [DOI: 10.1007/s11604-010-0534-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
94 Ito Y, Miyashiro I, Ishikawa T, Akazawa K, Fukui K, Katai H, Nunobe S, Oda I, Isobe Y, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Suzuki S, Kakeji Y, Sasako M, Bilchik A, Fujita M. Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases. J Epidemiol 2021;31:241-8. [PMID: 32281553 DOI: 10.2188/jea.JE20190351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
95 Lips DJ, Schutte HW, van der Linden RL, Dassen AE, Voogd AC, Bosscha K. Sentinel lymph node biopsy to direct treatment in gastric cancer. A systematic review of the literature. Eur J Surg Oncol. 2011;37:655-661. [PMID: 21636243 DOI: 10.1016/j.ejso.2011.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
96 Russo A, Li P, Strong VE. Differences in the multimodal treatment of gastric cancer: East versus west. J Surg Oncol 2017;115:603-14. [PMID: 28181265 DOI: 10.1002/jso.24517] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
97 Chung SJ, Park MJ, Kang SJ, Kang HY, Chung GE, Kim SG, Jung HC. Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea. Int J Cancer. 2012;131:2376-2384. [PMID: 22362223 DOI: 10.1002/ijc.27501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 5.3] [Reference Citation Analysis]
98 Goto R, Arai K, Kitada H, Ogoshi K, Hamashima C. Labor resource use for endoscopic gastric cancer screening in Japanese primary care settings: a work sampling study. PLoS One 2014;9:e88113. [PMID: 24523875 DOI: 10.1371/journal.pone.0088113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Xu ZQ, Broza YY, Ionsecu R, Tisch U, Ding L, Liu H, Song Q, Pan YY, Xiong FX, Gu KS, Sun GP, Chen ZD, Leja M, Haick H. A nanomaterial-based breath test for distinguishing gastric cancer from benign gastric conditions. Br J Cancer 2013;108:941-50. [PMID: 23462808 DOI: 10.1038/bjc.2013.44] [Cited by in Crossref: 138] [Cited by in F6Publishing: 113] [Article Influence: 17.3] [Reference Citation Analysis]
100 Choi SI, Park B, Joo J, Kim YI, Lee JY, Kim CG, Choi IJ, Kook MC, Cho SJ. Three-year interval for endoscopic screening may reduce the mortality in patients with gastric cancer. Surg Endosc 2019;33:861-9. [PMID: 30006847 DOI: 10.1007/s00464-018-6353-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
101 Vance RB Jr, Kubiliun N, Dunbar KB. How Do We Manage Gastric Intestinal Metaplasia? Dig Dis Sci. 2016;61:1870-1878. [PMID: 26984230 DOI: 10.1007/s10620-016-4107-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
102 Kobayashi Y, Watabe H, Yamada A, Hirata Y, Yamaji Y, Yoshida H, Koike K. Diagnostic yield of capsule endoscopy for gastric diseases. Abdom Imaging 2012;37:29-34. [PMID: 21748466 DOI: 10.1007/s00261-011-9777-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
103 Hoffman A, Manner H, Rey JW, Kiesslich R. A guide to multimodal endoscopy imaging for gastrointestinal malignancy - an early indicator. Nat Rev Gastroenterol Hepatol 2017;14:421-34. [PMID: 28611477 DOI: 10.1038/nrgastro.2017.46] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
104 Park JM, Kim SY, Shin GY, Choe Y, Cho HS, Lim CH, Cho YK, Choi MG. Implementation effect of institutional policy of EGD observation time on neoplasm detection. Gastrointest Endosc 2021;93:1152-9. [PMID: 32916166 DOI: 10.1016/j.gie.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Lee JS, Lee JH, Kim J, Na HK, Ahn JY, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer. J Korean Med Sci 2021;36:e88. [PMID: 33847079 DOI: 10.3346/jkms.2021.36.e88] [Reference Citation Analysis]
106 Shen L, Zhou C, Liu L, Zhang L, Lu D, Cai J, Zhao L, Chu R, Zhou J, Zhang J. Application of oral contrast trans-abdominal ultrasonography for initial screening of gastric cancer in rural areas of China. Digestive and Liver Disease 2017;49:918-23. [DOI: 10.1016/j.dld.2017.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
107 Zhang S, Khaliq J, Li D, Jiang X, Sun R, Li Y. Robotic total gastrectomy with π-shaped esophagojejunostomy using a linear stapler as a novel technique. World J Surg Oncol 2018;16:238. [PMID: 30577805 DOI: 10.1186/s12957-018-1542-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-713. [PMID: 24618998 DOI: 10.1158/1055-9965.epi-13-1057] [Cited by in Crossref: 681] [Cited by in F6Publishing: 419] [Article Influence: 97.3] [Reference Citation Analysis]
109 Matsumoto S, Yoshida Y. Efficacy of endoscopic screening in an isolated island: A case-control study. Indian J Gastroenterol. 2014;33:46-49. [PMID: 23996741 DOI: 10.1007/s12664-013-0378-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
110 Kim M, Kim HJ, Choi BY, Kim J, Song K, Noh S, Kim JC, Han DS, Kim S, Kim YS. Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis. Clinica Chimica Acta 2012;413:428-33. [DOI: 10.1016/j.cca.2011.10.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
111 Sekine S, Yoshida H, Jansen M, Kushima R. The Japanese Viewpoint on the Histopathology of Early Gastric Cancer. Adv Exp Med Biol 2016;908:331-46. [PMID: 27573779 DOI: 10.1007/978-3-319-41388-4_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
112 Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc. 2016;84:18-28. [PMID: 26940296 DOI: 10.1016/j.gie.2016.02.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 14.6] [Reference Citation Analysis]
113 Chen XZ, Huang CZ, Hu WX, Liu Y, Yao XQ. Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening. Chin Med J (Engl). 2018;131:1232-1239. [PMID: 29722342 DOI: 10.4103/0366-6999.231512] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
114 Nguyen PM, Putoczki TL. Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer? Cytokine 2019;118:8-18. [PMID: 29396054 DOI: 10.1016/j.cyto.2018.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
115 Hamashima C, Shabana M, Okada K, Okamoto M, Osaki Y. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci. 2015;106:1744-1749. [PMID: 26432528 DOI: 10.1111/cas.12829] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
116 Wang A, Shaukat A, Acosta RD, Bruining DH, Chandrasekhara V, Chathadi KV, Eloubeidi MA, Fanelli RD, Faulx AL, Fonkalsrud L, Gurudu SR, Kelsey LR, Khashab MA, Kothari S, Lightdale JR, Muthusamy VR, Pasha S, Saltzman JR, Yang J, Cash BD, Dewitt JM. Race and ethnicity considerations in GI endoscopy. Gastrointestinal Endoscopy 2015;82:593-9. [DOI: 10.1016/j.gie.2015.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
117 Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc. 2013;2013:241320. [PMID: 23533320 DOI: 10.1155/2013/241320] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
118 Hamashima C. Current issues and future perspectives of gastric cancer screening. World J Gastroenterol 2014;20:13767-74. [PMID: 25320514 DOI: 10.3748/wjg.v20.i38.13767] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 85] [Article Influence: 14.8] [Reference Citation Analysis]
119 Symeonidis D, Tepetes K. Techniques and Current Role of Sentinel Lymph Node (SLN) Concept in Gastric Cancer Surgery. Front Surg. 2018;5:77. [PMID: 30723718 DOI: 10.3389/fsurg.2018.00077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
120 Abadir A, Streutker C, Brezden-Masley C, Grin A, Kim YI. Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population. Clin Med Insights Gastroenterol 2012;5:43-50. [PMID: 24833933 DOI: 10.4137/CGast.S10070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
121 Dassen AE, Dikken JL, Bosscha K, Wouters MW, Cats A, van de Velde CJ, Coebergh JW, Lemmens VE. Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol. 2014;53:138-142. [PMID: 23829603 DOI: 10.3109/0284186x.2013.789139] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
122 Park JM, Huo SM, Lee HH, Lee BI, Song HJ, Choi MG. Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy. Gastroenterology. 2017;153:460-469. e1. [PMID: 28501581 DOI: 10.1053/j.gastro.2017.05.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
123 Yang Z, Guo X, Li G, Shi Y, Li L. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges. Cancer Lett. 2016;371:62-70. [PMID: 26577810 DOI: 10.1016/j.canlet.2015.11.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
124 Hamashima C. Benefits and harms of endoscopic screening for gastric cancer. World J Gastroenterol. 2016;22:6385-6392. [PMID: 27605874 DOI: 10.3748/wjg.v22.i28.6385] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
125 Oh JH, Jung SH, Hong SJ, Rhyu MG. DNA Methylation as Surrogate Marker For Gastric Cancer. J Cancer Prev 2015;20:172-8. [PMID: 26473155 DOI: 10.15430/JCP.2015.20.3.172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
126 Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29:895-905. [PMID: 26651251 DOI: 10.1016/j.bpg.2015.09.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 17.2] [Reference Citation Analysis]
127 Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17. [PMID: 25547086 DOI: 10.5009/gnl14118] [Cited by in Crossref: 121] [Cited by in F6Publishing: 94] [Article Influence: 20.2] [Reference Citation Analysis]
128 Han S, Hsu A, Wassef WY. An update in the endoscopic management of gastric cancer. Curr Opin Gastroenterol. 2016;32:492-500. [PMID: 27662061 DOI: 10.1097/mog.0000000000000318] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Najib Azmi A, Khor CJ, Ho KY, Pittayanon R, Rerknimitr R, Ratanachu-Ek T, Koay DS, Koh JC, Ho SH, Goh KL, Mahadeva S. Endoscopic Submucosal Dissection Outcomes for Gastroesophageal Tumors in Low Volume Units: A Multicenter Survey. Diagn Ther Endosc 2016;2016:5670564. [PMID: 27891047 DOI: 10.1155/2016/5670564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Huang RJ, Hwang JH. Improving the Early Diagnosis of Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:503-17. [PMID: 34053636 DOI: 10.1016/j.giec.2021.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol. 2016;111:1104-1113. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 11.4] [Reference Citation Analysis]
132 Mun YG, Choi MG, Lim CH, Lee HH, Kang DH, Park JM, Song KY. Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era. Clin Endosc 2018;51:478-84. [PMID: 29852731 DOI: 10.5946/ce.2018.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
133 Can MF, Yagci G, Cetiner S. Sentinel lymph node biopsy for gastric cancer: Where do we stand? World J Gastrointest Surg. 2011;3:131-137. [PMID: 22007282 DOI: 10.4240/wjgs.v3.i9.131] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
134 Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Uchida T, Yamaoka Y. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer. 2019;22:104-112. [PMID: 29934751 DOI: 10.1007/s10120-018-0844-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
135 Hamashima C, Shabana M, Okamoto M, Osaki Y, Kishimoto T. Survival analysis of patients with interval cancer undergoing gastric cancer screening by endoscopy. PLoS One. 2015;10:e0126796. [PMID: 26023768 DOI: 10.1371/journal.pone.0126796] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
136 Oze I, Shimada S, Nagasaki H, Akiyama Y, Watanabe M, Yatabe Y, Matsuo K, Yuasa Y. Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer. J Cancer Res Clin Oncol. 2017;143:551-554. [PMID: 27909811 DOI: 10.1007/s00432-016-2316-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
137 Yuan Y. A survey and evaluation of population-based screening for gastric cancer. Cancer Biol Med. 2013;10:72-80. [PMID: 23882421 DOI: 10.7497/j.issn.2095-3941.2013.02.002] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
138 Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol. 2011;32:3-11. [PMID: 21731209 DOI: 10.4103/0971-5851.81883] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
139 Hamashima C, Goto R. Potential capacity of endoscopic screening for gastric cancer in Japan. Cancer Sci 2017;108:101-7. [PMID: 27727490 DOI: 10.1111/cas.13100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
140 Chen Q, Yu L, Hao CQ, Wang JW, Liu SZ, Zhang M, Zhang SK, Guo LW, Quan PL, Zhao N. Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study. Cancer Med. 2016;5:2615-2622. [PMID: 27367362 DOI: 10.1002/cam4.812] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
141 Fukami N. ESD around the world: United States. Gastrointest Endosc Clin N Am. 2014;24:313-320. [PMID: 24679241 DOI: 10.1016/j.giec.2013.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
142 Coman RM, Gotoda T, Draganov PV. Training in endoscopic submucosal dissection. World J Gastrointest Endosc. 2013;5:369-378. [PMID: 23951392 DOI: 10.4253/wjge.v5.i8] [Reference Citation Analysis]
143 Mizuno S, Miki I, Ishida T, Yoshida M, Onoyama M, Azuma T, Habu Y, Inokuchi H, Ozasa K, Miki K. Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci. 2010;55:3132-3137. [PMID: 20204698 DOI: 10.1007/s10620-010-1154-0] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 6.3] [Reference Citation Analysis]
144 Kim B, Cho SJ. Endoscopic Screening and Surveillance for Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:489-501. [PMID: 34053635 DOI: 10.1016/j.giec.2021.03.004] [Reference Citation Analysis]
145 Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J 2012;53:248-57. [PMID: 22318810 DOI: 10.3349/ymj.2012.53.2.248] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
146 Gotoda T, Ishikawa H, Ohnishi H, Sugano K, Kusano C, Yokoi C, Matsuyama Y, Moriyasu F. Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy. Gastric Cancer 2015;18:605-11. [PMID: 25118857 DOI: 10.1007/s10120-014-0408-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
147 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
148 Sun L, Tu H, Chen T, Yuan Q, Liu J, Dong N, Yuan Y. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer. Sci Rep 2017;7:11621. [PMID: 28912586 DOI: 10.1038/s41598-017-12022-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
149 Hamashima C; Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines. Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol. 2018;48:673-683. [PMID: 29889263 DOI: 10.1093/jjco/hyy077] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 21.7] [Reference Citation Analysis]
150 Hayakawa M, Sato S, Diala I, Kodama M, Tomoeda-mori K, Haraguchi K, Tominaga K, Takenaka S. Screening for Oral Cancer Using Electrochemical Telomerase Assay. Electroanalysis 2016;28:503-7. [DOI: 10.1002/elan.201500426] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
151 Thrumurthy SG, Chaudry MA, Chau I, Allum W. Does surgery have a role in managing incurable gastric cancer? Nat Rev Clin Oncol 2015;12:676-82. [PMID: 26260039 DOI: 10.1038/nrclinonc.2015.132] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
152 de Almeida Artifon EL, Marinho FRT. Endoscopic screening for hereditary diffuse gastric cancer: One size does not fit all. Gastrointest Endosc. 2018;87:405-407. [PMID: 29406927 DOI: 10.1016/j.gie.2017.05.042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
153 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
154 Areia M, Carvalho R, Cadime AT, Rocha Gonçalves F, Dinis-Ribeiro M. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter. 2013;18:325-337. [PMID: 23566268 DOI: 10.1111/hel.12050] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 7.8] [Reference Citation Analysis]
155 Cheng CW, Chang CC, Patria YN, Chang RT, Liu YR, Li FA, Shih HM, Lin CY. Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer. Cancer Med 2018;7:64-74. [PMID: 29148252 DOI: 10.1002/cam4.1254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
156 Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014;47:497-503. [PMID: 25505714 DOI: 10.5946/ce.2014.47.6.497] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
157 Serrano M, Kikuste I, Dinis-Ribeiro M. Advanced endoscopic imaging for gastric cancer assessment: new insights with new optics? Best Pract Res Clin Gastroenterol. 2014;28:1079-1091. [PMID: 25439073 DOI: 10.1016/j.bpg.2014.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
158 Shah SC, Nunez H, Chiu S, Hazan A, Chen S, Wang S, Itzkowitz S, Jandorf L. Low baseline awareness of gastric cancer risk factors amongst at-risk multiracial/ethnic populations in New York City: results of a targeted, culturally sensitive pilot gastric cancer community outreach program. Ethn Health 2020;25:189-205. [PMID: 29115149 DOI: 10.1080/13557858.2017.1398317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
159 Can MF, Yagci G, Cetiner S. Systematic Review of Studies Investigating Sentinel Node Navigation Surgery and Lymphatic Mapping for Gastric Cancer. Journal of Laparoendoscopic & Advanced Surgical Techniques 2013;23:651-62. [DOI: 10.1089/lap.2012.0311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
160 Tsuda M, Asaka M, Kato M, Matsushima R, Fujimori K, Akino K, Kikuchi S, Lin Y, Sakamoto N. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Helicobacter. 2017;22. [PMID: 28771894 DOI: 10.1111/hel.12415] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
161 Huang Y, Li H, Long X, Liang X, Lu H. Lessons learned from upper gastrointestinal endoscopy in asymptomatic Chinese. Helicobacter 2021;26:e12803. [PMID: 33779026 DOI: 10.1111/hel.12803] [Reference Citation Analysis]
162 Nam JH, Choi IJ, Cho S, Kim CG, Jun JK, Choi KS, Nam B, Lee JH, Ryu KW, Kim Y. Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence: Endoscopy Interval in Gastric Cancer. Cancer 2012;118:4953-60. [DOI: 10.1002/cncr.27495] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
163 Zhang C, Zhang C, Wang Q, Li Z, Lin J, Wang H. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types. JAMA Netw Open 2020;3:e202950. [PMID: 32267515 DOI: 10.1001/jamanetworkopen.2020.2950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
164 Hamashima C, Okamoto M, Shabana M, Osaki Y, Kishimoto T. Sensitivity of endoscopic screening for gastric cancer by the incidence method. Int J Cancer. 2013;133:653-659. [PMID: 23364866 DOI: 10.1002/ijc.28065] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
165 Shah SC, Nakata C, Polydorides AD, Peek RM, Itzkowitz SH. Upper Endoscopy up to 3 Years Prior to a Diagnosis of Gastric Cancer Is Associated With Lower Stage of Disease in a USA Multiethnic Urban Population, a Retrospective Study. J Prev Med Public Health 2019;52:179-87. [PMID: 31163953 DOI: 10.3961/jpmph.18.262] [Reference Citation Analysis]
166 Zhang X, Li M, Chen S, Hu J, Guo Q, Liu R, Zheng H, Jin Z, Yuan Y, Xi Y, Hua B. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review. Gastroenterology. 2018;155:347-354.e349. [PMID: 29723507 DOI: 10.1053/j.gastro.2018.04.026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 24.0] [Reference Citation Analysis]
167 Oyama T. Stomach: Mucosal Neoplasias. In: Berr F, Oyama T, Ponchon T, Yahagi N, editors. Early Neoplasias of the Gastrointestinal Tract. Boston: Springer US; 2014. pp. 129-71. [DOI: 10.1007/978-1-4614-8292-5_8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Wang HS, Nie X, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD. Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis. Onco Targets Ther 2016;9:3849-60. [PMID: 27390525 DOI: 10.2147/OTT.S101782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
169 Durán-Acevedo CM, Jaimes-Mogollón AL, Gualdrón-Guerrero OE, Welearegay TG, Martinez-Marín JD, Caceres-Tarazona JM, Sánchez-Acevedo ZC, Beleño-Saenz KJ, Cindemir U, Österlund L, Ionescu R. Exhaled breath analysis for gastric cancer diagnosis in Colombian patients. Oncotarget 2018;9:28805-17. [PMID: 29988892 DOI: 10.18632/oncotarget.25331] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
170 Higashi T, Machii R, Aoki A, Hamashima C, Saito H. Evaluation and Revision of Checklists for Screening Facilities and Municipal Governmental Programs for Gastric Cancer and Colorectal Cancer Screening in Japan. Japanese Journal of Clinical Oncology 2010;40:1021-30. [DOI: 10.1093/jjco/hyq091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
171 Figueroa-Protti L, Soto-Molinari R, Calderón-Osorno M, Mora J, Alpízar-Alpízar W. Gastric Cancer in the Era of Immune Checkpoint Blockade. J Oncol 2019;2019:1079710. [PMID: 31662748 DOI: 10.1155/2019/1079710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
172 Hamashima C, Fukao A. Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities. Jpn J Clin Oncol. 2016;. [PMID: 27589938 DOI: 10.1093/jjco/hyw106] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
173 Xie W, Chen C, Han Z, Huang J, Liu X, Chen H, Zhang T, Chen S, Chen C, Lu M, Shen X, Xue X. CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly. Mol Carcinog 2020;59:339-52. [PMID: 31989722 DOI: 10.1002/mc.23158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Min YW, Lee JH. Endoscopic Resection for Early Gastric Cancer beyond Absolute Indication with Emphasis on Controversial Issues. J Gastric Cancer. 2014;14:7-14. [PMID: 24765532 DOI: 10.5230/jgc.2014.14.1.7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
175 Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One 2013;8:e79088. [PMID: 24236091 DOI: 10.1371/journal.pone.0079088] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 9.8] [Reference Citation Analysis]
176 Kim H, Hwang Y, Sung H, Jang J, Ahn C, Kim SG, Yoo KY, Park SK. Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort. Cancer Res Treat 2018;50:582-9. [PMID: 28602053 DOI: 10.4143/crt.2017.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
177 Dhalla F, da Silva SP, Lucas M, Travis S, Chapel H. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol. 2011;165:1-7. [PMID: 21470209 DOI: 10.1111/j.1365-2249.2011.04384.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
178 Kawamura T, Wada H, Sakiyama N, Ueda Y, Shirakawa A, Okada Y, Sanada K, Nakase K, Mandai K, Suzuki A, Kamaguchi M, Morita A, Nishioji K, Tanaka K, Mochizuki N, Uno K, Yokota I, Kobayashi M, Yasuda K. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29:569-575. [PMID: 28066945 DOI: 10.1111/den.12804] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
179 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
180 Ito Y, Nakayama T, Miyashiro I, Ioka A, Tsukuma H. Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan. BMC Cancer 2013;13:304. [PMID: 23800306 DOI: 10.1186/1471-2407-13-304] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
181 Tatemichi M, Sasazuki S, Inoue M, Tsugane S; JPHC Study Group. Clinical significance of IgG antibody titer against Helicobacter pylori. Helicobacter. 2009;14:231-236. [PMID: 19702853 DOI: 10.1111/j.1523-5378.2009.00681.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
182 Togo R, Ishihara K, Mabe K, Oizumi H, Ogawa T, Kato M, Sakamoto N, Nakajima S, Asaka M, Haseyama M. Preliminary study of automatic gastric cancer risk classification from photofluorography. World J Gastrointest Oncol 2018;10:62-70. [PMID: 29467917 DOI: 10.4251/wjgo.v10.i2.62] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Matsuoka T, Yashiro M. Biomarkers of gastric cancer: Current topics and future perspective. World J Gastroenterol. 2018;24:2818-2832. [PMID: 30018477 DOI: 10.3748/wjg.v24.i26.2818] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 80] [Article Influence: 31.3] [Reference Citation Analysis]
184 Itoh T, Saito M, Marugami N, Hirai T, Marugami A, Takahama J, Tanaka T, Kichikawa K. Correlation between the ABC classification and radiological findings for assessing gastric cancer risk. Jpn J Radiol 2015;33:636-44. [DOI: 10.1007/s11604-015-0469-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
185 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 60] [Article Influence: 20.7] [Reference Citation Analysis]
186 Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol. 2015;21:7954-7969. [PMID: 26185368 DOI: 10.3748/wjg.v21.i26.7954] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
187 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 14.4] [Reference Citation Analysis]
188 Gantuya B, Bolor D, Oyuntsetseg K, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Azzaya D, Uchida T, Matsuhisa T, Yamaoka Y. New observations regarding Helicobacter pylori and gastric cancer in Mongolia. Helicobacter 2018;23:e12491. [PMID: 29882322 DOI: 10.1111/hel.12491] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
189 Belloli L, Carlo-stella N, Ughi N, Marasini B. Cancer in Italian Patients with Systemic Sclerosis. Eur J Inflamm 2011;9:199-203. [DOI: 10.1177/1721727x1100900215] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
190 Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, You W, Li W, Pan K. Screening for gastric cancer in China: Advances, challenges and visions. Chin J Cancer Res 2021;33:168-80. [PMID: 34158737 DOI: 10.21147/j.issn.1000-9604.2021.02.05] [Reference Citation Analysis]
191 Hosokawa O. Can a serological test for selecting high-risk groups before endoscopy reduce gastric cancer deaths? Gastric Cancer 2013;16:280-1. [PMID: 23053825 DOI: 10.1007/s10120-012-0199-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
192 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
193 Katagiri H, Lefor AK, Kubota T, Mizokami K. Barium appendicitis: A single institution review in Japan. World J Gastrointest Surg 2016;8:651-5. [PMID: 27721929 DOI: 10.4240/wjgs.v8.i9.651] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
195 Chevallay M, Jung M, Berlth F, Seung-Hun C, Morel P, Mönig S. Laparoscopic Surgery for Gastric Cancer: The European Point of View. J Oncol 2019;2019:8738502. [PMID: 31214260 DOI: 10.1155/2019/8738502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
196 Hahm MI, Choi KS, Lee HY, Jun JK, Oh D, Park EC. Who participates in the gastric cancer screening and on-time rescreening in the National Cancer Screening Program? A population-based study in Korea. Cancer Sci. 2011;102:2241-2247. [PMID: 21895871 DOI: 10.1111/j.1349-7006.2011.02090.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
197 Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-713. [PMID: 24618998 DOI: 10.1158/1055-9965].] [Reference Citation Analysis]
198 Gonzalez S. Red-flag technologies in gastric neoplasia. Gastrointest Endosc Clin N Am 2013;23:581-95. [PMID: 23735104 DOI: 10.1016/j.giec.2013.03.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
199 Cidon EU, Centeno RG, Lagarto EG, Peral JI. HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain. J Oncol. 2011;2011:391564. [PMID: 22131990 DOI: 10.1155/2011/391564] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
200 Cho YK. How to Improve the Quality of Screening Endoscopy in Korea: National Endoscopy Quality Improvement Program. Clin Endosc. 2016;49:312-317. [PMID: 27484810 DOI: 10.5946/ce.2016.084] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
201 Song W, Chen CY, Xu JB, Ye JN, Wang L, Chen CQ, Zhang XH, Cai SR, Zhan WH, He YL. Pathological diagnosis is maybe non-essential for special gastric cancer: case reports and review. World J Gastroenterol. 2013;19:3904-3910. [PMID: 23840133 DOI: 10.3748/wjg.v19.i24.3904] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
202 Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Towards Personalization in the Curative Treatment of Gastric Cancer. Front Oncol. 2020;10:614907. [PMID: 33330111 DOI: 10.3389/fonc.2020.614907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Yin C, Gao B, Yang J, Wu J. Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer. Med Sci Monit Basic Res 2020;26:e920778. [PMID: 32201432 DOI: 10.12659/MSMBR.920778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
204 Kudo T, Kakizaki S, Sohara N, Onozato Y, Okamura S, Inui Y, Mori M. Analysis of ABC (D) stratification for screening patients with gastric cancer. World J Gastroenterol. 2011;17:4793-4798. [PMID: 22147980 DOI: 10.3748/wjg.v17.i43.4793] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
205 Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am 2016;45:413-28. [PMID: 27546840 DOI: 10.1016/j.gtc.2016.04.002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 14.8] [Reference Citation Analysis]
206 Matsumoto S, Ishikawa S, Yoshida Y. Reduction of gastric cancer mortality by endoscopic and radiographic screening in an isolated island: A retrospective cohort study.Aust J Rural Health. 2013;21:319-324. [PMID: 24299436 DOI: 10.1111/ajr.12064] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
207 Nakabayashi N, Hirose M, Suzuki R, Suzumiya J, Igawa M. How asymptomatic are early cancer patients of five organs based on registry data in Japan. Int J Clin Oncol 2018;23:999-1006. [PMID: 29785620 DOI: 10.1007/s10147-018-1287-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
208 Choi KS, Suh M. Screening for gastric cancer: the usefulness of endoscopy. Clin Endosc. 2014;47:490-496. [PMID: 25505713 DOI: 10.5946/ce.2014.47.6.490] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
209 Nam SY. Gastric Cancer Screening. In: Kim N, editor. Helicobacter pylori. Singapore: Springer; 2016. pp. 495-500. [DOI: 10.1007/978-981-287-706-2_49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
210 Sturgeon CM, Duffy MJ, Hofmann BR, Lamerz R, Fritsche HA, Gaarenstroom K, Bonfrer J, Ecke TH, Grossman HB, Hayes P, Hoffmann RT, Lerner SP, Löhe F, Louhimo J, Sawczuk I, Taketa K, Diamandis EP; National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Clin Chem 2010;56:e1-48. [PMID: 20207771 DOI: 10.1373/clinchem.2009.133124] [Cited by in Crossref: 146] [Cited by in F6Publishing: 115] [Article Influence: 13.3] [Reference Citation Analysis]
211 Dhingra R, Natov NS, Daaboul Y, Guelrud M, Cherukara A, Hung PF, Sterling MJ. Increased Risk of Progression to Gastric Adenocarcinoma in Patients with Non-dysplastic Gastric Intestinal Metaplasia Versus a Control Population. Dig Dis Sci 2020;65:3316-23. [PMID: 31916085 DOI: 10.1007/s10620-019-06031-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
212 Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review. BMC Gastroenterol 2017;17:157. [PMID: 29228909 DOI: 10.1186/s12876-017-0708-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
213 Park YM, Kim JH, Baik SJ, Park JJ, Youn YH, Park H. Clinical risk assessment for gastric cancer in asymptomatic population after a health check-up: An individualized consideration of the risk factors. Medicine (Baltimore) 2016;95:e5351. [PMID: 27858920 DOI: 10.1097/MD.0000000000005351] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
214 Yamamichi N, Hirano C, Shimamoto T, Minatsuki C, Takahashi Y, Nakayama C, Matsuda R, Fujishiro M, Konno-Shimizu M, Kato J. Associated factors of atrophic gastritis diagnosed by double-contrast upper gastrointestinal barium X-ray radiography: a cross-sectional study analyzing 6,901 healthy subjects in Japan. PLoS One. 2014;9:e111359. [PMID: 25343257 DOI: 10.1371/journal.pone.0111359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
215 Huang R, Xiao H, Zhou B, Song X, Zhang J, Wang C, Jiang Y, Chen D, Huang B. Serum Pepsinogen Levels Are Correlated With Age, Sex and the Level of Helicobacter pylori Infection in Healthy Individuals. The American Journal of the Medical Sciences 2016;352:481-6. [DOI: 10.1016/j.amjms.2016.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
216 Verlato G, Di Leo A, Rossi GM, de Manzoni G. Epidemiology of Gastric Cancer and Screening Programs. In: de Manzoni G, Roviello F, Siquini W, editors. Surgery in the Multimodal Management of Gastric Cancer. Milano: Springer Milan; 2012. pp. 1-7. [DOI: 10.1007/978-88-470-2318-5_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]